₹1,491.6
-132.6 (-8.2%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,657.46 | Bearish |
| 10-DMA | 1,629.97 | Bearish |
| 20-DMA | 1,595.27 | Bearish |
| 50-DMA | 1,468.4 | Bullish |
| 100-DMA | 1,207.98 | Bullish |
| 200-DMA | 1,030.83 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 54,649 | 47,444 | 49,773 | 46,402 | 39,665 |
| Total Expenditure | 50,521 | 43,919 | 47,114 | 44,196 | 37,119 |
| Other Income | 228 | 47 | 82 | 210 | 124 |
| Operating Profit | 4,356 | 3,571 | 2,740 | 2,416 | 2,670 |
| Interest | 1,198 | 1,216 | 1,225 | 1,064 | 715 |
| Depreciation | 1,153 | 932 | 849 | 744 | 1,010 |
| Profit Before Tax | 2,091 | 1,489 | 748 | 659 | 978 |
| Consolidated Net Profit | 1,550 | 1,109 | 628 | 553 | 765 |
| Adjusted EPS | 63 | 45 | 26 | 23 | 32 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 244 | 244 | 244 | 241 | 241 |
| Total Reserves | 10,170 | 8,976 | 8,153 | 7,309 | 7,096 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 3,959 | 3,760 | 3,570 | 2,721 | 3,192 |
| Other Current Liabilities | 3,586 | 3,266 | 2,535 | 3,556 | 3,409 |
| Short Term Borrowings | 2,906 | 2,921 | 4,119 | 4,332 | 4,438 |
| Total Liabilities | 35,142 | 31,893 | 31,041 | 30,476 | 29,740 |
| Capital Work in Progress | 687 | 503 | 775 | 1,142 | 1,255 |
| Long Term Loans & Advances | 564 | 496 | 570 | 326 | 398 |
| Currents Investments | --- | --- | --- | --- | --- |
| Short Term Loans and Advances | 2,010 | 1,421 | 1,358 | 1,308 | 1,448 |
| Total Current Assets | 18,043 | 17,470 | 17,877 | 18,179 | 18,807 |
| Total Assets | 35,142 | 31,893 | 31,041 | 30,476 | 29,740 |
| Adjusted Book Value | 426 | 377 | 344 | 314 | 305 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters